Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results

被引：0
|
作者：
Armstrong, April W. [1 ]
Lebwohl, Mark [2 ]
Warren, Richard B. [3 ,4 ]
Sofen, Howard [5 ]
Imafuku, Shinichi [6 ]
Ohtsuki, Mamitaro [7 ]
Spelman, Lynda [8 ]
Passeron, Thierry [9 ]
Papp, Kim A. [10 ,11 ]
Kisa, Renata M. [12 ]
Berger, Victoria [12 ,13 ]
Vritzali, Eleni
Hoyt, Kim [12 ]
Colombo, Matthew J. [12 ]
Banerjee, Subhashis [12 ]
Strober, Bruce [14 ]
Thaci, Diamant [15 ]
Blauvelt, Andrew [16 ]
机构：
[1] Univ Southern Calif, Keck Sch Med, Los Angeles, CA USA
[2] Icahn Sch Med Mt Sinai, Dept Dermatol, New York, NY USA
[3] Northern Care Alliance NHS Fdn Trust, Dermatol Ctr, Manchester, England
[4] Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, NIHR Manchester Biomed Res Ctr, Manchester, Lancs, England
[5] Univ Calif Los Angeles, Sch Med & Dermatol Res Associates, Los Angeles, CA USA
[6] Fukuoka Univ, Fac Med, Fukuoka, Japan
[7] Jichi Med Univ, Tochigi, Japan
[8] Verac Clin Res, Brisbane, Qld, Australia
[9] Univ Cote Azur, Univ Hosp Nice, Nice, France
[10] Alliance Clin Res & Prob Med Res, Waterloo, ON, Canada
[11] Univ Toronto, Toronto, ON, Canada
[12] Bristol Myers Squibb, Princeton, NJ USA
[13] Bristol Myers Squibb, Sissach, Switzerland
[14] Yale Univ, New Haven, CT USA
[15] Univ Lubeck, Inst & Comprehens Ctr Inflammat Med, Lubeck, Germany
[16] Oregon Med Res Ctr, Portland, OR USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2023年 / 75卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0261
引用
收藏
页码：509 / 511
页数：3
相关论文
共 50 条
  • [41] Safety and efficacy study on etanercept in patients with plaque psoriasis
    Costanzo, A
    Mazzotta, A
    Papoutsaki, M
    Chimenti, S
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 152 (01) : 187 - 189
  • [42] Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasis
    Perlmutter, Amy
    Cather, Jennifer
    Franks, Billy
    Jaracz, Eileen
    Menter, Alan
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (01) : 116 - 124
  • [43] Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
    Huang He
    Chen Min
    Wu Wenjuan
    Yang Tianhui
    Liu Hao
    Zhu Zhengwei
    Wang Wenjun
    Yang Sen
    Ding Xian
    Wang Hui
    Sheng Yujun
    Zhang Yaohua
    Li Min
    Zhang Xuejun
    中华医学杂志英文版, 2023, 136 (03)
  • [44] SAFETY AND EFFICACY OF IXEKIZUMAB TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM THE COAST PROGRAMME
    Deodhar, Atul
    Poddubnyy, Denis
    Rahman, Proton
    Bolce, Rebecca
    Leage, Soyi Liu
    Kronbergs, Andris
    Johnson, Caroline
    Leung, Ann
    van der Heijde, Desiree
    RHEUMATOLOGY, 2023, 62
  • [45] Efficacy and safety of ixekizumab in Chinese patients with plaque psoriasis
    Huang, He
    Chen, Min
    Wu, Wenjuan
    Yang, Tianhui
    Liu, Hao
    Zhu, Zhengwei
    Wang, Wenjun
    Yang, Sen
    Ding, Xian
    Wang, Hui
    Sheng, Yujun
    Zhang, Yaohua
    Li, Min
    Zhang, Xuejun
    CHINESE MEDICAL JOURNAL, 2023, 136 (03) : 360 - 361
  • [46] Efficacy and safety of secukinumab in moderate to severe plaque psoriasis
    Aparicio Rubio, Celia
    Monteagudo Santolaya, Emilio
    Cornejo Uixeda, Silvia
    Prieto Castello, Manuel
    Antonino de la Camara, Gonzalo
    Quintana Vergara, Belen
    Sanchez Alcaraz, Agustin
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (01) : 299 - 299
  • [47] Safety and efficacy of ixekizumab treatment in patients with axial spondyloarthritis: 3-year results from the COAST programme
    Deodhar, A.
    Poddubnyy, D.
    Rahman, P.
    Bolce, R.
    Liu-Leage, S.
    Kronbergs, A.
    Johnson, C.
    Leung, A.
    van der Heijde, D.
    Larsson, E.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 68 - 69
  • [48] SAFETY AND EFFICACY OF IXEKIZUMAB TREATMENT IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: 3-YEAR RESULTS FROM THE COAST PROGRAMME
    Deodhar, Atul
    Poddubnyy, Denis
    Rahman, Proton
    Bolce, Rebecca
    Liu-Leage, Soyi
    Kronbergs, Andris
    Johnson, Caroline
    Leung, Ann
    van der Heijde, Desiree
    Bird, Paul
    INTERNAL MEDICINE JOURNAL, 2023, 53 : 37 - 37
  • [49] Efficacy and safety of ponatinib in heavily pretreated leukemia patients in the PACE trial: 3-year results.
    Cortes, Jorge E.
    Kim, Dong Goo
    Pinilla-Ibarz, Javier
    Le Coutre, Philipp D.
    Paquette, Ronald
    Chuah, Charles
    Nicolini, Franck E.
    Apperley, Jane
    Khoury, Hanna Jean
    Talpaz, Moshe
    DiPersio, John F.
    Baccarani, Michele
    Lustgarten, Stephanie
    Haluska, Frank G.
    Guilhot, Francois
    Deininger, Michael W. N.
    Hochhaus, Andreas
    Hughes, Timothy P.
    Shah, Neil P.
    Kantarjian, Hagop M.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Clinical Utility of Deucravacitinib for the Management of Moderate to Severe Plaque Psoriasis
    Jin, Joy Q.
    Spencer, Riley K.
    Reddy, Vidhatha
    Bhutani, Tina
    Liao, Wilson
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 413 - 423
12345